Pasithea Therapeutics (KTTA) Stock Price
Pasithea Therapeutics Price
The stock trades about 71% above its 52-week low.
Pasithea Therapeutics stock price
Pasithea Therapeutics business model & stock analysis
Frequently asked questions about Pasithea Therapeutics
7 analysts currently rate the Pasithea Therapeutics stock: 6 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Pasithea Therapeutics share trades at 0.44 EUR (0.50 USD).
The Pasithea Therapeutics share (KTTA) is listed on 1 stock exchanges, including: NASDAQ (KTTA).
No history available for Pasithea Therapeutics.
The revenue cannot currently be calculated for Pasithea Therapeutics.
The expected profit of Pasithea Therapeutics is -947,720.05 USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Pasithea Therapeutics is currently -0.65. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Pasithea Therapeutics stock.
The P/S cannot be calculated for Pasithea Therapeutics currently.
The Eulerpool Quality Score for Pasithea Therapeutics is 2/10.
The ISIN of Pasithea Therapeutics is US70261F2020. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Pasithea Therapeutics is KTTA. The ticker symbol is used to trade Pasithea Therapeutics shares on the stock exchange.
Pasithea Therapeutics paid dividends every year for the past 0 years.
Pasithea Therapeutics is assigned to the 'Health' sector.
The dividends of Pasithea Therapeutics are distributed in USD.
Pasithea Therapeutics stock
Pasithea Therapeutics Peer Group
Pasithea Therapeutics Ticker
All fundamentals and in-depth analysis of Pasithea Therapeutics
Our stock analysis for Pasithea Therapeutics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pasithea Therapeutics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.